WindRose Health Investors, LLC, a New York-based healthcare private equity firm, announced that it has completed the acquisition of Bank’s Apothecary. Bank’s Apothecary will merge with WindRose’s portfolio companies Terrapin Pharmacy and Ganse Apothecary, significantly expanding the footprint of WindRose’s behavioral health pharmacy platform. Terms of the transaction were not disclosed.
Westcove Partners acted as financial advisor to Bank’s. Latham & Watkins LLP acted as legal advisor to WindRose, and Epstein, Becker & Green acted as legal advisor to Bank’s. Terms of the transaction were not disclosed.
Bank’s Apothecary is an independent accredited specialty pharmacy serving patients in 23 states. Based in Trevose, Pennsylvania, the company provides pharmacy services primarily to individuals with serious and persistent mental illness and substance use disorders.
According to the LevinPro HC database, this marks the 23rd acquisition of a specialty pharmacy during 2022. This also marks WindRose Health’s second acquisition in the subsector of the year. The company previously acquired Terrapin Pharmacy in January 2022.
